1. Home
  2. UNCY vs ISRL Comparison

UNCY vs ISRL Comparison

Compare UNCY & ISRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • ISRL
  • Stock Information
  • Founded
  • UNCY 2016
  • ISRL 2021
  • Country
  • UNCY United States
  • ISRL United States
  • Employees
  • UNCY N/A
  • ISRL N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • ISRL Blank Checks
  • Sector
  • UNCY Health Care
  • ISRL Finance
  • Exchange
  • UNCY Nasdaq
  • ISRL Nasdaq
  • Market Cap
  • UNCY 74.2M
  • ISRL 80.2M
  • IPO Year
  • UNCY 2021
  • ISRL 2023
  • Fundamental
  • Price
  • UNCY $4.93
  • ISRL $12.40
  • Analyst Decision
  • UNCY Strong Buy
  • ISRL
  • Analyst Count
  • UNCY 5
  • ISRL 0
  • Target Price
  • UNCY $55.20
  • ISRL N/A
  • AVG Volume (30 Days)
  • UNCY 419.1K
  • ISRL 8.1K
  • Earning Date
  • UNCY 11-12-2025
  • ISRL 01-01-0001
  • Dividend Yield
  • UNCY N/A
  • ISRL N/A
  • EPS Growth
  • UNCY N/A
  • ISRL N/A
  • EPS
  • UNCY N/A
  • ISRL 0.14
  • Revenue
  • UNCY N/A
  • ISRL N/A
  • Revenue This Year
  • UNCY N/A
  • ISRL N/A
  • Revenue Next Year
  • UNCY $19,912.34
  • ISRL N/A
  • P/E Ratio
  • UNCY N/A
  • ISRL $91.33
  • Revenue Growth
  • UNCY N/A
  • ISRL N/A
  • 52 Week Low
  • UNCY $3.71
  • ISRL $11.19
  • 52 Week High
  • UNCY $11.00
  • ISRL $14.00
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 66.90
  • ISRL 48.55
  • Support Level
  • UNCY $4.33
  • ISRL $12.09
  • Resistance Level
  • UNCY $4.81
  • ISRL $12.35
  • Average True Range (ATR)
  • UNCY 0.31
  • ISRL 0.20
  • MACD
  • UNCY 0.04
  • ISRL -0.03
  • Stochastic Oscillator
  • UNCY 70.07
  • ISRL 34.07

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About ISRL Israel Acquisitions Corp

Israel Acquisitions Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: